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Tiivistelmä −	  Referat	  –	  Abstract	  
Objective 
There is high case-fatality rate and loss of productive life-years related to aneurysmal 
subarachnoid hemorrhage (aSAH) but little data on long-term survival of SAH patients. We 
aim to evaluate long-term excess mortality and related risk factors after aSAH. 
Methods 
One year survivors (n=3080) after aSAH from Department of Neurosurgery in Helsinki 
between 1980 and 2007 were reviewed for this retrospective follow-up study. Follow-up 
started one year after SAH and continued until death or the end of 2008 (36 960 patient-
years). Mortality and relative survival ratio (RSR) were compared with matched general 
population. 
Results 
After 20 years, survivors of aSAH showed 18% excess mortality compared to general 
population. Risk factors included: old age; poor preoperative clinical condition; conservative 
aneurysm treatment; multiple aneurysms; and unfavourable clinical outcome at 3 months.  
Conclusion 
Even after initially favourable recovery, patients with aSAH experience excess mortality in 
the long run. Cardiovascular and cerebrovascular diseases are prominent in this population.  
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1	  Introduction	  
	  
Subarachnoid hemorrhage (SAH), caused by ruptured cerebral aneurysm, is a serious 
disease with high mortality (1,2). The most characteristic symptom of subarachnoid 
hemorrhage is sudden and severe headache, deterioration of consciousness, nausea and 
vomiting (3). For unknown reasons the incidence of subarachnoid hemorrhage is by far 
higher in Finland (21 / 100 000 person-years) and Japan than in most other parts of the 
world (8 / 100 000 person-years) (4). Yearly about 1000 Finns suffer from subarachnoid 
hemorrhage and almost half of them die, 15% even before reaching any medical care (2). 
Patients who survive the initial hours after the bleeding, three major neurological 
complications can threaten: rebleeding, delayed brain ischemia and hydrocephalus, all of 
which cause severe morbidity and mortality during the first months after SAH (5-7). 
The case- fatality rate for aneurysmal SAH is still close to 50% even though it has 
improved slowly over time thanks to better diagnostic tools and improved medical and 
surgical treatment strategies (2). Even nowadays, although only 5-10% of all strokes are 
caused by subarachnoid hemorrhage, the loss of productive life years is similar to that for 
cerebral infarction or intracerebral hemorrhage, since SAH strikes at fairly young age and 
is often fatal (8). Half of the patients are younger than 55 years (8).  Despite the known 
high case-fatality rate of SAH up to 6 months, there is only very little data on what 
happens to SAH patients later on. Is their life expectancy similar to that of somebody who 
has never had SAH or are they more prone to develop other medical conditions leading to 
morbidity and mortality? The aim of this study is to find out if there is excess mortality 
among patients with aneurysmal SAH in the long run, compared to matched general 
population. 
There are only few publications on long-term survival of SAH patients and their 
conclusions are slightly contradicting (1,9-12). Most studies have shown at least some 
excess mortality among SAH patients when compared to matched general population 
(1,9,11,12), whereas other results suggest quite the opposite (10). Knowledge on 
prospects of long-term survival and recovery after aneurysmal SAH is important for the 
patients, their families as well as for those deciding on the use of health economy 
resources. More information is needed concerning long-term mortality of SAH patients and 
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the risk factors related to impaired survival. Some of the risk factors may be treatable and 
this way the prognosis may be improved. For example, are multiple aneurysms 
predisposing factor for long-term mortality? Some patients are more prone to develop 
multiple aneurysms but it is not known whether these patients should be followed-up or 
treated more actively than those with just a single aneurysm.  
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2	  Patients	  and	  Methods	  
	  
Patients	  and	  Helsinki	  Cerebral	  Aneurysm	  Research-­‐	  Data	  base	  
	  
This is a single institution, retrospective follow-up study. There were altogether 4228 SAH 
patients treated between 1980 and 2007 at Department of Neurosurgery at Helsinki 
University Central Hospital, the sole provider of neurosurgical services for the catchment 
population of 1.8 million people living in Southern Finland. The clinical and radiological 
data of these patients was reviewed from Helsinki Cerebral Aneurysm Research- Data 
base; HeCARe- Data base, the largest data-base of its kind in the world. Patients with 
other than saccular aneurysms, foreign patients and patients treated primarily at other 
neurosurcigal centers (n=270) were excluded. Of the remaining 3958 saccular aneurysm 
patients treated between years 1980 and 2007, those patients, who survived a minimum of 
one year after the initial SAH were included in this study. There were 9 patients who 
survived but were lost from follow-up within the first year after SAH. There were 3080 
patients forming the final study sample. Characteristics of these 3080 subarachnoid 
hemorrhage patients are shown in Table 1. The mean age at the incidence of SAH was 49 
(range 1-88). For women the mean age was 51 and for men 46 years. 
 
Follow-­‐Up	  Data	  
	  
Follow-up period started one year after the initial SAH and continued until death or the end 
of the year 2008. The diagnosis of SAH was based on computed tomography (CT) and 
lumbar puncture. The ruptured aneurysm was identified with digital subtraction 
angiography (DSA), CT angiography (CTA) or MR angiography (MRA). Time of death or 
vital status at the end of the year 2008 was obtained from the Population Register Center, 
which contains this information on all residents in Finland. Patients’ initial clinical condition 
upon arrival at the hospital was described using Hunt & Hess (HH) and World Federation 
of Neurosurgical Societies (WFNS) grading scales (13,14). For the purpose of data 
analysis, patients were assigned either to active or conservative treatment group based on 
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the treatment they received. Treatment was considered conservative if the patient did not 
receive any kind of neurosurgical operative or endovascular intervention at any point 
during the whole follow-up period. Clinical condition at 3 months after the onset of SAH 
was evaluated using Glasgow outcome score (GOS) (15). The total follow-up time was   
36 960 patient-years with median follow-up of 12 years per patient (range 1–29 year(s)).  
 
 
Table	  1	   
Characteristics of 3080 aneurysmal subarachnoid hemorrhage patients who survived a 
minimum of one year and were treated in Helsinki University Hospital between 1980 and 
2007. 
 Total 
 
1700 (55%) 
1380 (45%) 
 
2177 (71%) 
590 (19%) 
211 (7%) 
68 (2%) 
34 (1%) 
 
593 (19%) 
1047 (34%) 
1094 (36%) 
138 (5%) 
206 (7%) 
Sex 
Female 
Male 
Number of aneurysms 
1 
2 
3 
4 
>4 
Location of ruptured aneurysm 
ICA 
MCA 
AcomA & A1 
Pericallosal artery 
Posterior circulation 
Active treatment 
Yes 
No 
 
3034 (99%) 
46 (1%) 
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Total 
736 (24%) 
1069 (35%) 
692 (23%) 
483 (16%) 
99 (3%) 
 
 
1827 (59%) 
561 (18%) 
160 (5%) 
335 (11%) 
196 (6%) 
 
1404 (50%) 
889 (32%) 
483 (17%) 
23 (1%) 
0 (0%) 
Preoperative HH 
1 
2 
3 
4 
5 
 
Preoperative WFNS 
1 
2 
3 
4 
5 
GOS at 3 months 
5 Good Recovery 
4 Moderate Disability 
3 Severe Disability 
2 Persistent vegetative state 
1 Death 
Vital status at the end of follow-up 
Alive 
Dead 
 
2367 (77%) 
713 (23%) 
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Statistical	  Methods	  
   
Excess mortality describes death that occurs before the average life expectancy for a 
person compared to other people with similar demographic characteristics. To measure 
excess mortality in this study a relative survival ratio (RSR) was calculated by dividing the 
observed survival of treated SAH patients by the expected survival. The expected survival 
was derived, using the Ederer II method (16), from the expected survival of the 
comparable general Finnish population matched with respect to age, sex, calendar time 
and place of residence. This data concerning comparable Finnish population was obtained 
from Statistics Finland. The 95% confidence intervals (CI) for annual RSR and cumulative 
relative survival estimates were calculated by assuming normal distribution. Statistical 
analysis has been carried out using SAS software (SAS Institute, Cary NC).  
 
	  
Ethical	  Aspects	  
	  
This study has been carried out following good ethical manner. It has been approved by 
the Ethics Committee of the Helsinki University Central Hospital, Dnro: 469/E0/04.  
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3	  Results	  	  
	  
Mortality	  
Mortality	  during	  the	  first	  year	  after	  aneurysmal	  SAH	  
	  
At the beginning of the follow-up, one year after the SAH, there were 3080 (78%) patients 
alive. 869 (22%) patients had died during the first year. In 94% of them the primary SAH 
was the cause of death.  Most of the patients who died during the first year (n=626, 72%) 
were in poor clinical condition (Hunt & Hess grades 4-5) on admission. Of all the patients 
who died during the first year, 87% died within the first 3 months. Due to expected poor 
prognosis, only 58% of the poor grade patients were treated actively.  
 
Causes	  of	  Death	  and	  Recurrent	  SAH	  	  
	  
During the follow-up, 713 patients (23%) died. Table 2 shows the causes of death in 
relation to follow-up periods. There were altogether 122 deaths caused by SAH over the 
whole time period. Majority of them (n=87, 71%) were related to the initial SAH. Re-
bleeding before treatment or rebleeding from previously treated aneurysm was cause of 
death in 18 patients and 17 died due to rupture of another aneurysm. The incidence for 
lethal recurrent SAH was 95 per 100 000 person-years, which is about three times the risk 
of getting SAH as a general Finnish adult (incidence 35/100 000) (17). 
Among the study group, the patients who survived a minimum of one year after SAH, the 
mean age at death was 65 (median 66; range 23- 90). The most common causes of death 
were cardiovascular disease (26%) and cancer (22%). Patients younger than 65 years 
also had cardiovascular disease as the leading cause of death (24%). Deaths caused by 
cerebrovascular disease were also common in our study group (15% for ≥ 65 years , 8%  
< 65 years). 
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Table	  2	  
Causes of death of the 713 SAH patients who died during follow-up. 
 
  Time from the beginning of follow-up to death 
Cause of death 0-5 years 
(n=3080)* 
6-10 years 
(n=2373) 
11-20 years 
(n=1689) 
21-29 years 
(n=584) 
Total 
(n=3080) 
Initial SAH and 
sequelae 
41 (21%) 27 (15%) 15 (6%) 4 (6%) 87 (12%) 
Rebleeding 
(same 
aneurysm) 
8 (4%) 5 (3%) 5 (2%) 0 (0%) 18 (3%) 
Another 
aneurysm 
ruptured 
5 (3%) 4 (2%) 4 (1%) 4 (6%) 17 (2%) 
Cerebrovascular 13 (7%) 20 (11%) 45 (17%) 7 (11%) 85 (12%) 
Cardiovascular 42 (22%) 52 (28%) 77 (28%) 14 (22%) 185 (26%) 
Cancer 40 (21%) 38 (21%) 59 (22%) 18 (28%) 154 (22%) 
Trauma 9 (5%) 8 (4%) 10 (4%) 4 (6%) 31 (4%) 
Suicide 7 (4%) 4 (2%) 3 (1%) 0 (0%) 14 (2%) 
Other 21 (11%) 23 (13%) 51 (19%) 14 (22%) 109 (15%) 
Not known 5 (3%) 4 (2%) 3 (1%) 1 (2%) 13 (2%) 
Total number of 
deaths 
191 (100%) 185 (100%) 272 (100%) 65 (100%) 713 (100%) 
* Patients at risk, total number of SAH patients at the beginning of follow-up period 
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Excess	  in	  Long-­‐	  Term	  Mortality	  
	  
There was constant excess mortality throughout the whole study period in study 
population compared to matched general population. Cumulative RSR was 0.94 (95% CI 
0.93 – 0.95) at 10 years, 0.82 (95% CI 0.79-0.85) at 20 years and 0.75 (95% CI 0.70 – 
0.81) at 28 years indicating excess mortality of 6%, 18% and 25% respectively. 
Cumulative relative survival ratios (RSRs) are presented in Figure 1.  
 
 
 
Figure	  1	  	  
Cumulative	  relative	  survival	  ratio	  (CRSR)	  of	  3080	  patients	  with	  ruptured	  saccular	  aneurysm	  compared	  to	  
matched	  general	  population	  as	  a	  function	  of	  time.	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Risk	  Factors	  of	  Long-­‐	  Term	  Excess	  Mortality	  
Age	  
Patients who were over 60 years old (n=583) had markedly higher excess mortality (10- 
year cumulative RSR 0.89, 95% CI 0.83 - 0.94, 20-year cumulative RSR 0.64, 95% CI 
0.51 – 0.78) than patients aged 44 or younger (n=1208, 10-year cumulative RSR 0.96 
95% CI 0,94 – 0,97, 20-year cumulative RSR 0.88, 95% CI 0.85 – 0.91).  
Even the youngest age group, patients aged 44 or younger, had significant excess long-
term mortality (25-year cumulative RSR 0.84, 95% CI 0.80 – 0.88) compared to matched 
general population. Of these younger patients, who died during the follow-up, 95% died 
before the age of 65. The patients aged 44 or younger seemed to have excess mortality 
caused by sequelae of SAH (n=37), cardiovascular disease (n=39) and cerebrovascular 
disease (n=14) accounting 20%, 21% and 8% of all causes of death respectively. 
 
Figure	  2	  
	  Cumulative	  RSRs	  as	  a	  function	  of	  follow-­‐up	  time	  for	  three	  age	  groups:	  ≤44	  years	  (blue),	  45–59	  years	  
(green),	  and	  ≥60	  years	  (purple).
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Multiple	  Aneurysms	  
Patients with a single aneurysm had better survival (n=2177, 25-year cumulative RSR 
0.82, 95% CI 0.78 – 0.87) than patients with multiple aneurysms (n=903, 25-year 
cumulative RSR 0.63 , 95% CI 0.55 – 0.71). New and lethal subarachnoid hemorrhage 
from another aneurysm was more common among patients with multiple aneurysms than 
in single aneurysm group (n=9, 20% vs. n=8, 15% of patients with SAH as the main cause 
of death).  
The portion of lethal rebleedings before treatment or from previously treated aneurysm 
was also slightly higher in multiple aneurysm group (n=9 vs. n=9 among single aneurysm 
patients , 20% and 17% of SAH related deaths). Other vascular causes of death were not 
overrepresented among multiple aneurysm patients: cardiovascular disease 24% vs. 27% 
in single aneurysm group and cerebrovascular causes 12% vs. 13 % respectively. 
Cumulative relative survival ratios (RSRs) are shown in figure 3. 
 
Figure	  3	  
Cumulative	  RSRs	  as	  a	  function	  of	  follow-­‐up	  time	  for	  patients	  with	  multiple	  aneurysms	  (green)	  and	  patients	  
with	  a	  single	  aneurysm	  (blue).
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Preoperative	  Clinical	  Condition	  
	  
Preoperative clinical condition (HH/WFNS) was related to long-term survival. Patients with 
severe neurological impairments before treatment had significantly higher excess long-
term mortality than patients with mild symptoms. Patients who had excess mortality within 
the first five-year period were mainly in poor preoperative clinical condition, HH grades 4 
and 5. Later on, patients with good preoperative condition also started to show clear 
excess mortality. The cumulative RSR at 20 years of follow-up for HH 1: 0.91 (95% CI 0.86 
– 0.95), for HH 2: 0.86 (95% CI 0.81 – 0.90), for HH 3: 0.72 (95% CI 0.65 – 0.78), for HH 
4: 0.73 (95% CI 0.62 – 0.83) and for HH 5: 0.49 (95%CI 0.19 - 0.77). 
 
 
Figure	  5	  
Cumulative RSRs according to patients´ preoperative clinical condition (Hunt & Hess grade) and 
as a function of time. 
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Conservative	  Treatment	  
	  
Considering all the aneurysmal SAH patients (n=4228) who got treatment between 1980 
and 2007, total of 414 patients were treated conservatively. Most of the them (n=368, 
89%) died within the first year after the SAH. At one year, only 46 (11%) of the 
conservatively treated patients were alive. Conservative treatment resulted in significantly 
impaired long-term survival, cumulative RSR at 25 years 0.38 (95% CI 0.20 – 0.59), in 
comparison to patients with actively treated aneurysm having 25-year cumulative RSR  
0.78 (95% CI 0.74 – 0.82).   
Conservatively treated patients were mainly in worse clinical condition at admission to the 
hospital (Hunt & Hess 4-5 43%, Hunt & Hess 3 33%) than patients who were operated 
(Hunt & Hess 4-5 19%, Hunt & Hess 3 22%). They also had relatively more lethal 
rebleedings than patients with operated aneurysms (n=5, 33% vs. n=13, 16% of patients 
with SAH as the main cause of death). 
 
Aneurysm	  Location	  and	  Gender	  
	  
Aneurysm location did not have impact on long-term survival. During the first year after 
SAH greater portion of SAH patients with aneurysm of posterior circulation died than 
patients with aneurysms of other locations. Later on, there were not significant differences 
between groups; in the long run, cumulative RSRs of all loci showed excess mortality 
(Figure 6). 
Patients’ gender did not affect long-term excess mortality: 10-year cumulative RSRs 0.94 
(95% CI 0.92- 0.95) for women and 0.94 (95% CI 0.92- 0.96) for men, 20-year cumulative 
RSRs 0.82 (95% CI 0.78- 0.85) for women and 0.84 (95% CI 0.79- 0.88) for men. 
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Figure	  6	  
Cumulative RSRs of SAH patients, divided into groups according to the location of ruptured 
aneurysm and presented as a function of time. 
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Outcome	  at	  3	  months	  
	  
As expected, patients who had serious disabilities at three months after SAH also had 
greater long-term excess mortality when compared to patients with good recovery 
according to Glasgow outcome score (Figure 7). Considering patients with GOS 2, 67% of 
them died because of SAH.  
Remarkably, patients with good recovery after the SAH also had notable excess in long-
term mortality but they did not start to show it until after 8 years of follow-up (25-year 
cumulative RSR for GOS 5 0.85, 95% CI 0.80-0.90). Patients with good recovery at 3 
months had cardiovascular disease (31%) and cancer (27%) as the leading causes of 
death. They had the lowest portion of deaths caused by SAH (9% GOS 5 vs. 12% GOS 4 
and 20% GOS 3).  
	  
Figure	  7	  
Cumulative	  RSRs	  as	  a	  function	  of	  time	  according	  to	  patients´	  clinical	  outcome	  at	  3	  months	  after	  SAH:	  GOS	  5	  
Good	  Recovery	  (yellow),	  GOS	  4	  Moderate	  Disability	  (purple),	  GOS	  3	  Severe	  Disability	  (green)	  and	  GOS	  2	  
Persistent	  vegetative	  state	  (blue). 
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4	  Discussion	  
 
In this follow-up study of 3080 aneurysmal SAH patients, there was constant excess 
mortality throughout the whole study period. The cumulative relative survival ratios showed 
18% excess mortality at 20 years compared to the matched Finnish general population. 
Even young patients and patients with good recovery showed excess mortality in the long 
run. The excess mortality became more obvious after ten years of follow-up and was 
highlighted during the following decades. The advantages of this study were: (a) 
exceptionally large number of study patients; (b) extensive follow-up of nearly 37 000 
patient-years; (c) low number of excluded patients in comparison to the whole study group 
and (d) detailed population registers and mortality statistics in Finland, which include all 
Finnish residents. The fact that this is a retrospective follow-up study caused some 
selection bias that needs to be considered when looking at the results. 
 
Long-­‐term	  Mortality	  after	  SAH	  	  
	  
So far, there is only limited knowledge on the long-term follow-up of aneurysmal SAH 
patients. Most studies report outcome at relatively early phase of recovery, most often 
three to 12 months after the SAH (2,8,17,18) There are very few studies which address 
patients’ outcome more than five years after the initial SAH (1,9-12). The general belief 
has been, that after successful recovery, SAH should have no further effect on patients’ 
survival. However, what some studies have shown is, that despite surviving the initial 
aSAH, many of the patients die earlier than their peers (1,9,11,12). 	  
In earlier Finnish study of 1537 SAH patients by Ronkainen et al. it was suggested that 
aneurysmal SAH might be a manifestation of general vascular disease (9). The study by 
Wermer et al. from the Netherlands suggested that treatment of cardiovascular risk factors 
should be considered due to elevated incidence of vascular events (11). The most 
common causes of death in our study group were cardiovascular disease (26%) and 
cancer (22%). Among patients with good recovery at 3 months, these were highlighted as 
the leading causes of death (31% and 27% respectively). Patients younger than 65 years 
had cardiovascular disease as the leading cause of death (24%). In the general Finnish 
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population lethal cardiovascular events are less frequent in under 65-year-old Finns (19% 
in men and 7% in women) but common in over 65-year-old Finns (28%) (19). This 
indicates that SAH patients have increased mortality due to cardiovascular disease at 
younger age. The increased risk of cardiovascular disease may be due to general 
cardiovascular disease, the impact of SAH on the cardiovascular system or due to the 
shared risk factors like elevated blood pressure and smoking. Our results suggest that the 
treatment of cardiovascular risk factors should be emphasized on patients younger than 
65. 
Deaths caused by cerebrovascular disease were also overrepresented among our study 
patients (15% for ≥ 65 years, 8% < 65 years) compared to general Finnish population 
(11% for ≥ 65 years, 6% < 65 years) (19). A significant cause of mortality were sequelae of 
the initial SAH. They counted about one fifth of all deaths in the first five- year period but 
were less prominent later on. It is possible that long-term rehabilitation and follow-up of 
SAH patients is not optimal nowadays. The effects and disabilities caused by SAH may 
not be paid enough attention to in the years following SAH, which may increase morbidity 
and mortality.  
The risk of lethal recurrent SAH was not high but remained elevated after primary SAH. 
Long-term risk of rebleeding from previously treated aneurysm seemed to be greatest 
during the first five- year period of follow-up and decreased after that. The risk of new, 
lethal SAH from another aneurysm did not lower in a long run. It was higher among 
patients with multiple aneurysms than among patients with a single aneurysm. The total 
risk of lethal, recurrent SAH was about three times as high as the risk of SAH striking for 
the first time. 
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Long-­‐term	  Excess	  Mortality	  
	  
There are only five publications on long-term mortality of aneurysmal SAH patients (1,9-
12). Three of these studies come from Finland, one from Iceland and one from the 
Netherlands, indicating how difficult it is to carry out a reliable long-term follow-up study. 
The results are partly contradicting, especially when it comes to survival of young patients 
and the patients with good recovery after SAH.  
In our study, the total cumulative relative survival ratios showed 18% excess mortality at 
20 years compared to matched general Finnish population (cumulative RSR 0.82, 95% CI 
0.79- 0.85). The latest population-based study of 1746 one-year survivors of SAH in 
Eastern Finland with median follow-up 12 years showed 12% excess mortality at 15 years 
compared to matched general population (cumulative RSR 0.88, 95% CI 0.85- 0.91) (12). 
These findings are similar, both presenting significant long-term excess mortality after 
SAH. Eventhough both of these studies are from Finland, the method of calculating RSRs, 
using matched general population, should fade the effect of the population it is based upon 
and describe only the effect of SAH.  
 
Risk	  Factors	  for	  Excess	  Mortality	  
	  
Risk factors for long-term excess mortality turned out to be: age (especially above 60 
years); poor preoperative clinical condition; conservative treatment; multiple aneurysms; 
and unfavourable clinical outcome at 3 months after the SAH.  
Age	  
The patients aged 60 and older were in the greatest risk of dying earlier than their fellow 
citizens according to our series. This is in line with the recent study of Huttunen et al. in 
which age above 64 years was an independent risk factor for long-term excess mortality 
(12). In the Dutch study of 752 SAH patients by Wermer et al., young patients had the 
highest excess mortality and earlier study by Ronkainen et al. suggested the same (9,11). 
In our study, age group of 60-88 showed the highest excess mortality. But, there was 
significant excess mortality of 16% at 25-years of follow-up even in our youngest age 
group (1-44 years). These patients died at ages much younger than their peers, with 
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sequelae of the initial SAH, cardiovascular and cerebrovascular disease representing half 
of all the causes of death. 
Preoperative	  Clinical	  Condition	  
It was expected that poor preoperative clinical condition leads to impaired survival. 
Surprisingly, even patients with good preoperative clinical condition showed excess 
mortality during follow-up. This was seen in using both HH and WFNS grading scales. 
There was excess mortality of 9% at 20 years for patients with HH 1 and 14% at 20 years 
for patients with HH 2. Similar results were seen in the study of Huttunen et al. who 
reported 11% excess mortality at 15 years for patients with HH 1-2 on admission (12).  
Conservative	  Treatment	  
The conservatively treated patients had markedly higher excess mortality than patients 
who got active treatment. The selection bias, related to this study, affects especially 
allocation into these two treatment groups. The conservative treated patients were initially 
in worse clinical condition and were expected to have worse prognosis in comparison to 
actively treated patients. In addition, 89% of the conservatively treated patients died during 
the first year of follow-up, as compared to the 14% of actively treated. 	  
Multiple	  Aneurysms	  
We got new information concerning the prognosis of the patients with multiple aneurysms. 
They had not only higher excess mortality but also increased risk of dying due to rupture of 
another aneurysm than patients with just single aneurysm. It is not known if treating all the 
aneurysms early enough will decrease their mortality but this is something we would like to 
study in the future.  It is possible that patients with multiple aneurysms have more severe 
general vascular disease, and multiplicity of aneurysms is just a representation of the 
severity of the disease. When looking at causes of death this can not be verified; 
cardiovascular disease (27% for single aneurysm group, 24% for multiple aneurysm 
patients), and cerebrovascular disease (13% and 12% respectively). 
Clinical	  Outcome	  at	  3	  Months	  
It has been a generally accepted belief, that after good recovery, SAH patients should 
have the same life expectancy as other people. An Icelandic study of only 44 SAH patients 
showed no excess mortality among patients with good recovery at 6 months (1). Also in a 
Finnish series of 280 ruptured distal anterior cerebral artery aneurysm patients, there was 
no long-term excess mortality for patients with good recovery at 12 months (10). The first 
study was limited by a small number, whereas in the latter one certain distinct features of 
	   23	  
the distal anterior cerebral artery aneurysms such as their frontal and cortical location, may 
explain the relatively better outcome when compared to all aneurysm locations. Our 
results seem to be in line with the other two larger studies which included all aneurysm 
sites. They reported excess mortality (9% or twice that of the general population) even in 
patients with initial good recovery (9,12). In our study, patients with good recovery at 3 
months showed 15% cumulative excess mortality in 25-year follow-up. The excess 
mortality was not clearly seen during the first ten years but became evident after that. So, 
contrary to the general belief, even patients with good initial recovery after aSAH are 
burdened by their SAH experience and die earlier than matched population.  
Gender	  and	  Location	  of	  Aneurysm	  –No	  Related	  Risk	  
Gender or location of the ruptured aneurysm had no effect on long-term survival according 
to our data. These results are not supported by the study of Huttunen et al., which 
suggested that male sex and basilar tip aneurysms were related to long-term excess 
mortality (12). In our study the mortality related to basilar tip aneurysms was elevated 
during the first year after the SAH but later on it did not differ from the mortality of the 
patients with aneurysms at other locations. 
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5	  Conclusions	  
	  
 
Despite initial good recovery aneurysmal SAH patients are burdened by the SAH in the 
long run. They show significant long-term excess mortality when compared with matched 
general population. Risk factors for excess mortality are old age, poor preoperative clinical 
condition, conservative aneurysm treatment, multiple aneurysms and unfavourable clinical 
outcome at 3 months after SAH. Cardiovascular disease at younger age and 
cerebrovascular events are overrepresented as causes of death, which indicates the 
importance of treatment of cardio- and cerebrovascular risk factors after SAH. 
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